Last updated: April 17, 2024
Sponsor: Tanta University
Overall Status: Active - Recruiting
Phase
2/3
Condition
Soft Tissue Infections
Treatment
Lactoferrin
Metformin
Clinical Study ID
NCT06181422
metformin and lactoferrin
Ages 18-75 All Genders
Study Summary
Eligibility Criteria
Inclusion
Inclusion Criteria:
- Inclusion Criteria:
- Age more than 18 years old.
- A diagnosis of sepsis according to the latest Sepsis definition.11
- Estimated GFR >45 ml/minute.
Exclusion
Exclusion Criteria: Exclusion Criteria:
- Pregnancy and breast feeding.
- End stage hepatic disease.
- End stage renal disease -
Study Design
Total Participants: 60
Treatment Group(s): 2
Primary Treatment: Lactoferrin
Phase: 2/3
Study Start date:
April 01, 2024
Estimated Completion Date:
June 09, 2024
Study Description
Connect with a study center
Tanta
Tanta,
EgyptActive - Recruiting
Not the study for you?
Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.